Gavi Approves Bold 2026-2030 Strategy for Vaccine Access and

The Gavi Board has approved the Vaccine Alliance's strategic plan for 2026-2030, aiming to accelerate global immunization efforts. This new strategy, known as "Gavi 6.0," seeks to protect more people against a wider range of diseases, faster than ever before. Key decisions from the two-day meeting held in Geneva include…

Related Keywords

Geneva , Genè , Switzerland , Paris , France General , France , Amarie Coll Seck , David Sidwell , Onei Uetela , Karen Sorenson , Investment Committee , Global Forum For Vaccine Sovereignty , Evaluation Advisory Committee , African Union , Vaccine Alliance , Gavi Board , African Vaccine Manufacturing Accelerator , Day Zero Financing Facility , Portfolio Expansion , Vaccine Investment Strategy , Vaccine Manufacturing Accelerator , Zero Financing Facility , Global Forum , Vaccine Sovereignty , Appointed Board Member , Board Member , Finance Committee , Evaluation Advisory ,